Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kegyes

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cell Death Discovery|August 13, 2025
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapiesDavid Kegyes, Andrei Tat, Alin Stefan Vizitiu, et al.
Frontiers in Immunology|August 27, 2025
Challenges in the preclinical design and assessment of CAR-T cellsRadu Tomai, Javier De Las Rivas, Bogdan Fetica, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Blood Reviews|November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseasesAdrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.
Journal of Cellular and Molecular Medicine|May 6, 2026
Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's LymphomasMaria Santa, Diana Cenariu, Adrian-Bogdan Tigu, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cell Death Discovery|August 13, 2025
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapiesDavid Kegyes, Andrei Tat, Alin Stefan Vizitiu, et al.
Frontiers in Immunology|August 27, 2025
Challenges in the preclinical design and assessment of CAR-T cellsRadu Tomai, Javier De Las Rivas, Bogdan Fetica, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Blood Reviews|November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseasesAdrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.
Journal of Cellular and Molecular Medicine|May 6, 2026
Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's LymphomasMaria Santa, Diana Cenariu, Adrian-Bogdan Tigu, et al.
Pageof 3